The genetics of primary biliary cholangitis

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

PURPOSE OF REVIEW: Primary biliary cholangitis (PBC) is a female predominant chronic autoimmune disease of the intrahepatic bile ducts and with a long latent period. It is crucial to understand how genetics contribute to the disease. RECENT FINDINGS: Geo-epidemiological studies in PBC have provided evidence of familial risk; case-control studies and genome wide association studies have identified various human leukocyte antigen (HLA) and non-HLA alleles that are associated with PBC. However, these alleles are non-PBC specific and most of the identified non-HLA loci were also found to be susceptible genes in other autoimmune diseases and different between study populations. SUMMARY: Patients with PBC are often asymptomatic and often left undiagnosed. There are no known HLA and non-HLA alleles specific for PBC. Global effort and novel approaches such as epigenetics directed at identification of genetic risk factors will greatly facilitate accurate and timely diagnosis, which will improve prognosis and increase treatment options.

Original languageEnglish (US)
Pages (from-to)93-98
Number of pages6
JournalCurrent Opinion in Gastroenterology
Volume35
Issue number2
DOIs
StatePublished - Mar 1 2019

Fingerprint

Cholangitis
HLA Antigens
Alleles
Autoimmune Diseases
Intrahepatic Bile Ducts
Genome-Wide Association Study
Epigenomics
Case-Control Studies
Epidemiologic Studies
Chronic Disease
Population
Genes

ASJC Scopus subject areas

  • Gastroenterology

Cite this

The genetics of primary biliary cholangitis. / Tanaka, Atsushi; Leung, Patrick S; Gershwin, M. Eric.

In: Current Opinion in Gastroenterology, Vol. 35, No. 2, 01.03.2019, p. 93-98.

Research output: Contribution to journalArticle

@article{bc583782c14a4431862ad8b2f3ff652e,
title = "The genetics of primary biliary cholangitis",
abstract = "PURPOSE OF REVIEW: Primary biliary cholangitis (PBC) is a female predominant chronic autoimmune disease of the intrahepatic bile ducts and with a long latent period. It is crucial to understand how genetics contribute to the disease. RECENT FINDINGS: Geo-epidemiological studies in PBC have provided evidence of familial risk; case-control studies and genome wide association studies have identified various human leukocyte antigen (HLA) and non-HLA alleles that are associated with PBC. However, these alleles are non-PBC specific and most of the identified non-HLA loci were also found to be susceptible genes in other autoimmune diseases and different between study populations. SUMMARY: Patients with PBC are often asymptomatic and often left undiagnosed. There are no known HLA and non-HLA alleles specific for PBC. Global effort and novel approaches such as epigenetics directed at identification of genetic risk factors will greatly facilitate accurate and timely diagnosis, which will improve prognosis and increase treatment options.",
author = "Atsushi Tanaka and Leung, {Patrick S} and Gershwin, {M. Eric}",
year = "2019",
month = "3",
day = "1",
doi = "10.1097/MOG.0000000000000507",
language = "English (US)",
volume = "35",
pages = "93--98",
journal = "Current Opinion in Gastroenterology",
issn = "0267-1379",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - The genetics of primary biliary cholangitis

AU - Tanaka, Atsushi

AU - Leung, Patrick S

AU - Gershwin, M. Eric

PY - 2019/3/1

Y1 - 2019/3/1

N2 - PURPOSE OF REVIEW: Primary biliary cholangitis (PBC) is a female predominant chronic autoimmune disease of the intrahepatic bile ducts and with a long latent period. It is crucial to understand how genetics contribute to the disease. RECENT FINDINGS: Geo-epidemiological studies in PBC have provided evidence of familial risk; case-control studies and genome wide association studies have identified various human leukocyte antigen (HLA) and non-HLA alleles that are associated with PBC. However, these alleles are non-PBC specific and most of the identified non-HLA loci were also found to be susceptible genes in other autoimmune diseases and different between study populations. SUMMARY: Patients with PBC are often asymptomatic and often left undiagnosed. There are no known HLA and non-HLA alleles specific for PBC. Global effort and novel approaches such as epigenetics directed at identification of genetic risk factors will greatly facilitate accurate and timely diagnosis, which will improve prognosis and increase treatment options.

AB - PURPOSE OF REVIEW: Primary biliary cholangitis (PBC) is a female predominant chronic autoimmune disease of the intrahepatic bile ducts and with a long latent period. It is crucial to understand how genetics contribute to the disease. RECENT FINDINGS: Geo-epidemiological studies in PBC have provided evidence of familial risk; case-control studies and genome wide association studies have identified various human leukocyte antigen (HLA) and non-HLA alleles that are associated with PBC. However, these alleles are non-PBC specific and most of the identified non-HLA loci were also found to be susceptible genes in other autoimmune diseases and different between study populations. SUMMARY: Patients with PBC are often asymptomatic and often left undiagnosed. There are no known HLA and non-HLA alleles specific for PBC. Global effort and novel approaches such as epigenetics directed at identification of genetic risk factors will greatly facilitate accurate and timely diagnosis, which will improve prognosis and increase treatment options.

UR - http://www.scopus.com/inward/record.url?scp=85060592279&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060592279&partnerID=8YFLogxK

U2 - 10.1097/MOG.0000000000000507

DO - 10.1097/MOG.0000000000000507

M3 - Article

C2 - 30601157

AN - SCOPUS:85060592279

VL - 35

SP - 93

EP - 98

JO - Current Opinion in Gastroenterology

JF - Current Opinion in Gastroenterology

SN - 0267-1379

IS - 2

ER -